The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Author:
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/14728222.2016.1206891
Reference193 articles.
1. Differentiation of Effector CD4 T Cell Populations
2. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage
3. TH17 cells in development: an updated view of their molecular identity and genetic programming
4. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer;Heliyon;2024-09
2. Epidermal growth factor receptor and programmed cell death‐1 expression levels in peripheral T cell subsets of patients with non‐small cell lung cancer;Scandinavian Journal of Immunology;2024-07-29
3. The immune microenvironment of lung adenocarcinoma featured with ground‐glass nodules;Thoracic Cancer;2024-06-24
4. IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway;Cell Death Discovery;2024-05-13
5. Combining multi-mode thermal therapy with IL-6 and IL-17A neutralization amplifies antitumor immunity to facilitate long-term survival in LLC1-bearing mice;Med-X;2024-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3